Constipation on Ozempic, Wegovy or Mounjaro: What Helps?

Constipation during GLP-1 treatment is common enough that it deserves a plan, not embarrassment.

People using Ozempic, Wegovy or Mounjaro often eat less. They may also drink less, move less because they feel tired, or avoid bulky foods because they feel full quickly. The medicine itself can slow digestive movement. Put those factors together and bowel habits can change.

For some people this is mild. For others it becomes uncomfortable enough to threaten the whole treatment.

The goal is not to suffer through it. The goal is to adjust the system early.

Why constipation can happen

There is rarely one single cause.

Meal size may drop. Fibre intake may fall. Fluid intake may fall. Appetite may be so low that the person eats irregularly. Some people increase protein but forget fibre and fluids. Others suddenly add large amounts of fibre and become more bloated.

GLP-1 medicines can also slow gastric emptying and affect gut motility. This is a documented class effect of GLP-1 receptor agonist medicines, not an unexpected reaction. It helps with appetite control, but it can also make digestion feel slower.

What often helps

Start with fluid. This sounds basic because it is basic. If food intake falls and fluid intake falls at the same time, constipation becomes more likely.

Then check fibre. Fibre helps many people, but the dose matters. Increasing fibre too quickly can worsen gas and bloating. A gradual increase is usually more tolerable.

Next, check protein balance. Many people are told to prioritise protein during weight loss, which is reasonable. But a high-protein, low-fibre, low-fluid pattern is a common constipation trap.

Movement matters too. Walking after meals and regular physical activity can support bowel function. Strength training is important for muscle preservation, but simple daily movement also has digestive value.

Meal timing can help. Very irregular eating may worsen bowel rhythm. Smaller, structured meals tend to work better for many patients on GLP-1 treatment.

Some people need over-the-counter support. That choice should be individual, especially if there are other medical conditions, other medications, pregnancy, older age, severe symptoms, or a history of bowel disease. Do not keep escalating laxatives repeatedly without medical advice.

When to contact a clinician

Constipation should not be ignored if it becomes severe.

Seek medical advice urgently if constipation is associated with severe abdominal pain, repeated vomiting, marked abdominal swelling, blood in stool, fever, inability to pass gas, or sudden worsening of symptoms.

Also contact a clinician if constipation is new and severe but not clearly explained by changes in treatment, eating or fluid intake. This warrants review to rule out other causes.

And seek advice if constipation persists despite basic measures, or if dose escalation repeatedly triggers significant symptoms.

Why this matters for maintenance

A person who feels sick will not stay with the plan.

Constipation, nausea and reflux are not small side issues. They affect adherence, food quality, mood and confidence. If the treatment becomes unpleasant, people may stop early or under-eat in a way that harms muscle and energy.

Managing symptoms early can help patients stay nourished, maintain muscle-supporting habits and reduce the risk of stopping treatment in a way that leads to regain.

Sources

1. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021;384:989-1002. Randomized trial, n=1961. Constipation was among the gastrointestinal adverse events reported with semaglutide.
2. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022;387(3):205-216. Randomized trial, n=2539. Constipation was among the gastrointestinal adverse events reported.